Pathios Therapeutics are world-leading experts with unique expertise in GPCR drug development, focused on GPR65 as a high-value immunology target with robust genetic links to multiple human diseases. Our clinical-stage oncology programme leverages cutting-edge proprietary genetic insights, transcrip...See more
Headquarters:
United Kingdom of Great Britain and Northern Ireland
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2017 (8 years)
Address:
99 PARK DRIVE; MILTON, OXFORDSHIRE OX14 4RR, GB
At a glanceLOW
spending power
